(HealthDay)—MiSight, the first contact lens indicated to slow the progression of myopia in children ages…
View More FDA approves first contact lens that slows myopia progression
Home »
FDA Approves Supplemental New Drug Application to Expand Cinvanti (aprepitant) Label for IV Push
SAN DIEGO, Feb. 26, 2019 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology…
View More FDA Approves Supplemental New Drug Application to Expand Cinvanti (aprepitant) Label for IV Push
FDA approves mavyret for children, adolescents with hep C
(HealthDay)—Mavyret (glecaprevir and pibrentasvir) tablets are now approved to treat all six genotypes of hepatitis…
View More FDA approves mavyret for children, adolescents with hep C
FDA Approves Ibrance (palbociclib) for the Treatment of Men with HR+, HER2- Metastatic Breast Cancer
April 4, 2019 — Pfizer (NYSE:PFE) today announced that the U.S. Food and Drug Administration…
View More FDA Approves Ibrance (palbociclib) for the Treatment of Men with HR+, HER2- Metastatic Breast Cancer
FDA Approves Use of 0.5 mL Dose of Fluzone Quadrivalent (influenza vaccine) in Children as Young as 6 Months of Age
BRIDGEWATER, N.J., Jan. 23, 2019 /PRNewswire/ — The U.S. Food and Drug Administration has approved…
View More FDA Approves Use of 0.5 mL Dose of Fluzone Quadrivalent (influenza vaccine) in Children as Young as 6 Months of Age
FDA Approves Vaxelis
BRIDGEWATER, N.J. and KENILWORTH, N.J. – December 26, 2018 –The U.S. Food and Drug Administration…
View More FDA Approves Vaxelis